We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLAB icon
701
Silicon Laboratories
SLAB
$7.2B
$799K 0.01%
13,580
ORI icon
702
Old Republic International
ORI
$10.5B
$795K 0.01%
45,098
-4,576
-9% -$87.1K
BIV icon
703
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$793K 0.01%
9,044
-1,000
-10% -$87.7K
AIV
704
Aimco
AIV
$381M
$792K 0.01%
129,515
-1,066
-0.8% -$6.42K
KATE
705
DELISTED
Kate Spade & Company
KATE
$788K 0.01%
45,988
+7,630
+20% +$148K
DXYN
706
DELISTED
Dixie Group Inc
DXYN
$783K 0.01%
156,673
+8,500
+6% +$35K
EVHC
707
DELISTED
Envision Healthcare Holdings Inc
EVHC
$779K 0.01%
11,680
+7
+0.1% +$482
HDB icon
708
HDFC Bank
HDB
$122B
$766K 0.01%
42,640
-1,944
-4% -$34.2K
SUSA icon
709
iShares ESG Optimized MSCI USA ETF
SUSA
$4.16B
$763K 0.01%
16,766
ZGNX
710
DELISTED
Zogenix, Inc.
ZGNX
$759K 0.01%
66,400
-129,100
-66% -$1.19M
BAL
711
DELISTED
iPath Bloomberg Cotton Subindex Total Return ETN due June 24, 2038
BAL
$757K 0.01%
+16,781
New +$781K
INGR icon
712
Ingredion
INGR
$6.51B
$754K 0.01%
5,668
+1,586
+39% +$212K
IYR icon
713
iShares US Real Estate ETF
IYR
$4.67B
$750K 0.01%
9,304
+872
+10% +$72.2K
ROST icon
714
Ross Stores
ROST
$81.2B
$748K 0.01%
11,629
+2,298
+25% +$141K
PSA icon
715
Public Storage
PSA
$61.1B
$737K 0.01%
3,302
-40
-1% -$9.34K
MGPI icon
716
MGP Ingredients
MGPI
$379M
$733K 0.01%
18,100
-2,300
-11% -$88.9K
XYZ
717
Block Inc
XYZ
$50.1B
$733K 0.01%
62,823
+5,093
+9% +$55.6K
GNRC icon
718
Generac Holdings
GNRC
$12.8B
$730K 0.01%
20,110
-44,965
-69% -$1.63M
SNAK
719
DELISTED
Inventure Foods, Inc.
SNAK
$717K 0.01%
76,286
-3,800
-5% -$34.3K
ACH
720
Accendra Health
ACH
$227M
$714K 0.01%
20,572
+757
+4% +$26.5K
AAPL icon
721
CALL
Apple
AAPL
$4.54T
$712K 0.01%
+25,200
New +$667K
TIVO
722
CALL
DELISTED
Tivo Inc
TIVO
$703K 0.01%
+36,100
New +$713K
UNIT
723
Uniti Group
UNIT
$2.35B
$702K 0.01%
+22,350
New +$686K
SBRA icon
724
Sabra Healthcare REIT
SBRA
$5.32B
$699K 0.01%
27,755
+11,573
+72% +$277K
SCZ icon
725
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$697K 0.01%
13,300
+7,155
+116% +$363K

Similar funds

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.